Ionpath Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 44
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $18M
Latest Deal Amount
  • Investors
  • 12

Ionpath General Information

Description

Developer of an ion beam imaging technology designed to provide analysis of tissue biopsies. The company's imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen or FFPE, enabling health care providers to provide diagnosis of cancer for improving human health.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 960 O'Brien Drive
  • Menlo Park, CA 94025
  • United States
+1 (833) 000-0000

Ionpath Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ionpath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 24-Sep-2020 $18M 0000 0000 Completed Generating Revenue
3. Debt - PPP 14-Apr-2020 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Jul-2019 $30.4M $33M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A1) $2.6M $2.6M 000.00 Completed Startup
To view Ionpath’s complete valuation and funding history, request access »

Ionpath Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00 00 00 00 00.00
Series A-1 0,000,000 00.000000 00.00 00.00 00 00.00 0.00
Series A 5,355,296 $0.000100 $3.58 $3.58 1x $3.58 11.16%
To view Ionpath’s complete cap table history, request access »

Ionpath Executive Team (7)

Name Title Board Seat Contact Info
Harris Fienberg Ph.D Co-Founder & Chief Executive Officer
Sander Gubbens Ph.D Chief Executive Officer & Board Member
John Lowe Executive
Michael Angelo Ph.D Co-Founder & Board Member
Sean Bendall Ph.D Co-Founder & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Ionpath Board Members (9)

Name Representing Role Since
Aaron Sandoski Norwich Ventures Board Observer 000 0000
Frank Lee Ph.D Self Board Member 000 0000
Jenny Rooke Ph.D Self Board Observer 000 0000
Michael Angelo Ph.D Ionpath Co-Founder & Board Member 000 0000
Michael Dybbs Ph.D Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Ionpath Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ionpath Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bruker Corporation Minority 000 0000 000000 0
DragonScale Ventures Venture Capital Minority 000 0000 000000 0
ND Capital Venture Capital Minority 000 0000 000000 0
Norwich Ventures Venture Capital Minority 000 0000 000000 0
Paladin Capital Group Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »